CAR T cells need a pitstop to win the race

Area of Science:

• Immunology
• Cancer Biology
• Cellular Therapeutics

Background:

• T cell exhaustion is a state of T cell dysfunction.
• Prolonged T cell receptor (TCR)-driven stimulation is a known cause of T cell exhaustion.
• T cell exhaustion limits the effectiveness of T cell-based therapies, including chimeric antigen receptor (CAR) T cells.

Purpose of the Study:

• To investigate methods for preventing T cell exhaustion in CAR T cells.
• To determine if early cessation of CAR T cell tonic signaling can maintain T cell function.
• To assess the impact of preventing exhaustion on anti-tumor responses.

Main Methods:

• Utilized a mouse model for CAR T cell therapy.
• Manipulated the duration of tonic signaling in CAR T cells.
• Analyzed epigenetic modifications associated with T cell exhaustion.
• Evaluated the persistence and function of CAR T cells in vivo.
• Assessed tumor regression in response to CAR T cell therapy.

Main Results:

• Prolonged TCR-driven stimulation led to the development of T cell exhaustion.
• Early cessation of CAR T cell tonic signaling prevented the stabilization of exhaustion-associated epigenetic programs.
• CAR T cells with early signal cessation exhibited enhanced anti-tumor activity and prolonged persistence.
• Preventing exhaustion in CAR T cells resulted in improved tumor control.

Conclusions:

• Early termination of CAR T cell tonic signaling is a viable strategy to prevent T cell exhaustion.
• This approach can enhance the efficacy and durability of CAR T cell therapy.
• Findings suggest a novel method to improve CAR T cell-based cancer treatments.